Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Victoria Hall et al.
Summary: This study investigated the duration and effectiveness of immunity among healthcare workers in the United Kingdom. It found that two doses of the BNT162b2 vaccine provided high short-term protection against SARS-CoV-2 infection, but this protection significantly decreased after six months. However, infection-acquired immunity boosted by vaccination remained high, even more than one year after infection.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Yasset Perez-Riverol et al.
Summary: PRIDE is the largest data repository of mass spectrometry-based proteomics data in the world, with around 500 datasets submitted per month. In addition to continuous improvements in data pipelines and infrastructure, PRIDE has developed the Spectra Archive and MAGE-TAB file format to enhance sample metadata annotation and access to mass spectra.
NUCLEIC ACIDS RESEARCH
(2022)
Article
Immunology
Timothy A. Bates et al.
Summary: This study found that individuals who previously recovered from COVID-19 and received vaccination (hybrid immunity) have enhanced immune responses. The effects of post-vaccination breakthrough infections on humoral immune response needs further investigation. However, regardless of whether it occurs before or after vaccination, natural infection substantially boosts the quantity, quality, and breadth of humoral immune response.
SCIENCE IMMUNOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Matthew Gagne et al.
Summary: This study shows that both mRNA-1273 and mRNA-Omicron generate comparable immunity and protection after booster doses, and are able to neutralize the Omicron variant.
Article
Infectious Diseases
Jan Van Elslande et al.
Summary: We found that IgG anti-spike levels can persist up to 3 months after vaccination with two doses of the BNT162b2 mRNA vaccine in healthcare workers. The antibody response is stronger in previously infected vaccinated individuals compared to uninfected individuals, and stronger after vaccination compared to mild natural infection.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
(2022)
Article
Immunology
Aurelien Sokal et al.
Summary: The Omicron variant of SARS-CoV-2 is able to escape neutralization by antibodies elicited by vaccines and previous infection. However, the memory B cells (MBCs) generated by mRNA vaccines can still recognize and neutralize the Omicron variant to some extent, providing a certain level of protection for vaccinated individuals.
Article
Infectious Diseases
Thiago Cerqueira-Silva et al.
Summary: This study assessed the effectiveness of four COVID-19 vaccines against symptomatic infection, hospitalisation, and death among individuals with previous SARS-CoV-2 infection. The findings suggest that all four vaccines can provide additional protection for individuals who have recovered from COVID-19.
LANCET INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Peter Nordstrom et al.
Summary: This retrospective cohort study investigated the effectiveness of COVID-19 vaccination in individuals who had previously been infected with SARS-CoV-2. The study found that natural immunity provided protection against SARS-CoV-2 infection and COVID-19 hospitalization for up to 20 months. Vaccination further reduced the risk of reinfection and hospitalization for up to 9 months, although the differences in absolute numbers, especially in hospitalizations, were small.
LANCET INFECTIOUS DISEASES
(2022)
Article
Multidisciplinary Sciences
Khadija Khan et al.
Summary: This study measured the neutralization capacity of individuals infected with Omicron sublineage BA.1 in South Africa. The results showed that vaccination and Omicron BA.1 infection together can provide protection against Delta and other variants, while infection with Omicron BA.1 alone offers limited cross-protection despite moderate enhancement.
Article
Immunology
Rahul K. Suryawanshi et al.
Summary: This study shows that infection with the Omicron variant induces a limited immune response and may not provide broad protection against non-Omicron variants in unvaccinated individuals. However, Omicron breakthrough infections enhance pre-existing immunity elicited by vaccines. This has important implications for controlling the pandemic and the use of vaccines.
NATURE REVIEWS IMMUNOLOGY
(2022)
Article
Virology
Bas Calcoen et al.
Summary: This study monitored the mid- and long-term adaptive immune response and breakthrough infections in healthcare workers who received the BNT162b2 vaccine. The results showed that the vaccine-induced humoral and cellular immune responses were not correlated in individuals without breakthrough infections. The decline in humoral immunity over time was more pronounced compared to cellular immunity. Additionally, a high incidence of symptomatic breakthrough infections caused by alpha and delta variants of concern was reported.
Article
Multidisciplinary Sciences
Georg M. N. Behrens et al.
Summary: Heterologous prime/boost vaccination with a vector-based approach followed by an mRNA vaccine has been found to induce better protective immunity compared to homologous vaccination. A third vaccine dose enhances the waning anti-spike IgG and restores neutralizing antibody responses against several variants of the virus, except for the Omicron variant.
NATURE COMMUNICATIONS
(2022)
Letter
Medicine, General & Internal
Diana Zhong et al.
Summary: This study compares the durability of antibodies in individuals who received mRNA SARS-CoV-2 vaccine with prior infection and those without infection.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Biochemistry & Molecular Biology
Aurelien Sokal et al.
Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.
Article
Multidisciplinary Sciences
Leonidas Stamatatos et al.
Summary: The study found that vaccination of both previously infected individuals and those who were not infected resulted in increased neutralizing antibody titers, with previously infected individuals showing a greater boost in neutralizing titers. Vaccination of naive individuals also elicited cross-neutralizing responses, but at lower titers.
Article
Immunology
Aurelien Sokal et al.
Summary: This study examined the MBC responses in recovered and naive individuals after mRNA vaccination against SARS-CoV-2, finding that the MBC pool in recovered individuals expanded selectively, matured further, and had potent neutralizers against VOCs. Naive individuals displayed weaker neutralizing serum responses, but a significant portion of their RBD-specific MBCs showed high affinity to multiple VOCs, suggesting potential efficient response to VOCs in naive vaccinees.
Article
Biochemistry & Molecular Biology
Aviv Omer et al.
NUCLEIC ACIDS RESEARCH
(2020)
Article
Multidisciplinary Sciences
Moriah Gidoni et al.
NATURE COMMUNICATIONS
(2019)
Article
Biochemical Research Methods
Florian Rohart et al.
PLOS COMPUTATIONAL BIOLOGY
(2017)
Article
Biochemistry & Molecular Biology
Jian Ye et al.
NUCLEIC ACIDS RESEARCH
(2013)
Article
Biochemical Research Methods
Kim-Anh Le Cao et al.
BMC BIOINFORMATICS
(2011)
Article
Biochemistry & Molecular Biology
Francois Ehrenmann et al.
NUCLEIC ACIDS RESEARCH
(2010)
Article
Biochemistry & Molecular Biology
Marie-Paule Lefranc et al.
NUCLEIC ACIDS RESEARCH
(2009)
